Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Recombinant interferon beta-1a

Known as: INTERFERON BETA-1A,RECOMBINANT, Interferon Beta-1A 
A synthetic version of naturally occurring interferons that have immunomodulatory, antiviral and antiproliferative activities. It may exert antitumor… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Fenstermacher JD. In normal rat, intraventricularly administered insulin-like growth factor-1 is rapidly cleared from CSF with… Expand
Is this relevant?
Review
2009
Review
2009
  • H. P. Hartung
  • Expert opinion on pharmacotherapy
  • 2009
  • Corpus ID: 30814153
BACKGROUND There is at present no cure for multiple sclerosis (MS), and existing therapies are designed primarily to prevent… Expand
Is this relevant?
Review
2009
Review
2009
Background: There is at present no cure for multiple sclerosis (MS), and existing therapies are designed primarily to prevent… Expand
Is this relevant?
2003
2003
 
Is this relevant?
2002
2002
Although effective conventional therapies are available to treat basal cell carcinoma (BCC), undesirable side effects, including… Expand
Is this relevant?
2000
2000
Objective: To evaluate the efficacy of recombinant interferon beta (IFNβ)-1a in the treatment of ALS. Background: It has been… Expand
Is this relevant?
2000
2000
OBJECTIVE To evaluate the efficacy of recombinant interferon beta (IFNbeta)-1a in the treatment of ALS. BACKGROUND It has been… Expand
Is this relevant?
2000
2000
AIMS Interferon alpha monotherapy induces a sustained response in less than 20% of patients treated for chronic hepatitis C… Expand
Is this relevant?
1995
1995
The design and conduct of a randomized, double-blinded, placebo-controlled, multicenter, phase III study of recombinant… Expand
  • table 2
  • figure 1
  • table 4
  • table 5
  • table 3
Is this relevant?
1995
1995
The design and conduct of a randomized, double-blinded, placebo-controlled, multicenter, phase III study of recombinant… Expand
Is this relevant?